243
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Estimating treatment effects in clinical crossover trials

&
Pages 191-233 | Published online: 29 Mar 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ijaz Iqbal, M. H. Tahir & Syed Skahir Ali Ghazali. (2009) Circular First- and Second-Order Balanced Repeated Measurements Designs. Communications in Statistics - Theory and Methods 39:2, pages 228-240.
Read now
Nancy D. Smith. (1998) Discussion of “estimating treatment effects in clinical crossover trials”: A Regulatory perspective . Journal of Biopharmaceutical Statistics 8:2, pages 243-247.
Read now
Gary G. Koch. (1998) Discussion of “estimating treatment effects in clinical crossover trials”. Journal of Biopharmaceutical Statistics 8:2, pages 239-242.
Read now
Byron Jones & Jixian Wang. (1998) Comments on “estimating treatment effects in clinical crossover trials”. Journal of Biopharmaceutical Statistics 8:2, pages 235-238.
Read now

Articles from other publishers (17)

Stephen Senn. (2022) The design and analysis of vaccine trials for COVID ‐19 for the purpose of estimating efficacy . Pharmaceutical Statistics 21:4, pages 790-807.
Crossref
Stephen Senn. (2022) Viewpoint : Do not resurrect the two‐stage procedure . Pharmaceutical Statistics 21:4, pages 808-814.
Crossref
Quan Zhang, Youssef Toubouti & Bradley P Carlin. (2015) Design and analysis of Bayesian adaptive crossover trials for evaluating contact lens safety and efficacy. Statistical Methods in Medical Research 26:3, pages 1216-1236.
Crossref
Andrew P. Grieve. (2017) Response-adaptive clinical trials: case studies in the medical literature. Pharmaceutical Statistics 16:1, pages 64-86.
Crossref
Stephen Senn. 2012. Encyclopedia of Biopharmaceutical Statistics, Third Edition. Encyclopedia of Biopharmaceutical Statistics, Third Edition 380 385 .
M Rashid. 2012. Encyclopedia of Biopharmaceutical Statistics, Third Edition. Encyclopedia of Biopharmaceutical Statistics, Third Edition 1114 1124 .
Nicola S. Anstice & John R. Phillips. (2011) Effect of Dual-Focus Soft Contact Lens Wear on Axial Myopia Progression in Children. Ophthalmology 118:6, pages 1152-1161.
Crossref
Shein-Chung ChowM.Mushfiqur Rashid. 2010. Encyclopedia of Biopharmaceutical Statistics. Encyclopedia of Biopharmaceutical Statistics 1114 1124 .
Shein-Chung ChowStephen Senn. 2010. Encyclopedia of Biopharmaceutical Statistics. Encyclopedia of Biopharmaceutical Statistics 380 385 .
Andrew P. Grieve. (2007) 25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel. Pharmaceutical Statistics 6:4, pages 261-281.
Crossref
S. S. Lund, L. Tarnow, C. D. A. Stehouwer, C. G. Schalkwijk, M. Frandsen, U. M. Smidt, O. Pedersen, H.-H. Parving & A. Vaag. (2007) Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes, Obesity and Metabolism 9:3, pages 394-407.
Crossref
N. T. Longford. (2005) Editorial: Model Selection and Efficiency—is ‘Which Model …?’ the Right Question?. Journal of the Royal Statistical Society Series A: Statistics in Society 168:3, pages 469-472.
Crossref
Stephen Senn, Giuseppina D'Angelo & Diane Potvin. (2004) Carry‐over in cross‐over trials in bioequivalence: theoretical concerns and empirical evidence. Pharmaceutical Statistics 3:2, pages 133-142.
Crossref
M Rashid. 2003. Encyclopedia of Biopharmaceutical Statistics, Second edition. Encyclopedia of Biopharmaceutical Statistics, Second edition 870 883 .
Ramón Dı́az-Uriarte. (2002) Incorrect analysis of crossover trials in animal behaviour research. Animal Behaviour 63:4, pages 815-822.
Crossref
Nicholas T. Longford. (2001) Synthetic estimators with moderating influence: the carry‐over in cross‐over trials revisited. Statistics in Medicine 20:21, pages 3189-3203.
Crossref
Stephen Senn. (2001) Cross-over trials in drug development: theory and practice. Journal of Statistical Planning and Inference 96:1, pages 29-40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.